Cargando…
Metastatic Metaplastic Breast Cancer Successfully Treated with Adriamycin and Cisplatin
Metaplastic breast cancer (MBC) is characterized by the histological presence of a mixture of epithelial and mesenchymal-like elements. However, MBC responds poorly to chemotherapy. Due to its rarity, there is no well-defined treatment for MBC. Herein, we report the case of a 56-year-old woman who u...
Autores principales: | Hayashino, Kenta, Zaitsu, Junichi, Kuraoka, Kazuya, Hirata, Taizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017233/ https://www.ncbi.nlm.nih.gov/pubmed/35908970 http://dx.doi.org/10.2169/internalmedicine.9380-22 |
Ejemplares similares
-
Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2018) -
Metaplastic breast cancer with chondroid differentiation
por: Myint, Zin W., et al.
Publicado: (2015) -
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
por: Gorshein, Elan, et al.
Publicado: (2021) -
Invasive Mucinous Adenocarcinoma with Acute Respiratory Distress Syndrome Diagnosed by Autopsy Findings
por: Kawasumi, Muneo, et al.
Publicado: (2022) -
Metaplastic Breast Cancer in a Patient with Neurofibromatosis
por: Chaudhry, Umar Shafique, et al.
Publicado: (2015)